Citadel Advisors LLC Has $40.87 Million Stock Holdings in Chemed Co. (NYSE:CHE)

Citadel Advisors LLC grew its stake in shares of Chemed Co. (NYSE:CHE) by 197.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 77,143 shares of the company’s stock after purchasing an additional 51,206 shares during the period. Citadel Advisors LLC owned approximately 0.51% of Chemed worth $40,870,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in CHE. Raymond James Financial Inc. bought a new stake in shares of Chemed during the fourth quarter worth about $42,023,000. Signal Advisors Wealth LLC increased its holdings in Chemed by 60.7% during the 4th quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company’s stock worth $2,647,000 after purchasing an additional 1,886 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of Chemed by 10.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 136,182 shares of the company’s stock worth $72,149,000 after purchasing an additional 13,394 shares during the last quarter. Bright Rock Capital Management LLC bought a new position in shares of Chemed in the fourth quarter valued at approximately $1,060,000. Finally, Fifth Third Bancorp boosted its position in shares of Chemed by 12.1% during the fourth quarter. Fifth Third Bancorp now owns 4,934 shares of the company’s stock valued at $2,614,000 after buying an additional 531 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have weighed in on CHE shares. Royal Bank of Canada raised their price objective on Chemed from $667.00 to $674.00 and gave the company an “outperform” rating in a research note on Monday, April 28th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th.

Insider Transactions at Chemed

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the business’s stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the sale, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Spencer S. Lee sold 1,500 shares of the stock in a transaction dated Wednesday, May 7th. The stock was sold at an average price of $577.86, for a total transaction of $866,790.00. Following the transaction, the executive vice president now owns 16,127 shares of the company’s stock, valued at $9,319,148.22. This represents a 8.51 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 6,000 shares of company stock worth $3,534,135 in the last quarter. Insiders own 3.29% of the company’s stock.

Chemed Stock Up 0.7 %

CHE stock opened at $572.90 on Friday. The firm has a market cap of $8.38 billion, a PE ratio of 28.95, a P/E/G ratio of 2.15 and a beta of 0.59. The business has a 50 day moving average of $589.27 and a 200-day moving average of $565.29. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $623.61.

Chemed (NYSE:CHE) last announced its earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.59 by $0.04. The firm had revenue of $646.94 million during the quarter, compared to analyst estimates of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business’s revenue was up 9.8% compared to the same quarter last year. During the same period last year, the firm posted $5.20 EPS. On average, research analysts expect that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s dividend payout ratio is currently 9.74%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.